Mylan's planned megamerger with Pfizer's Upjohn generics unit has had a rocky road to approval, with the novel coronavirus pandemic snagging regulatory review. Despite the delay, Mylan isn't twiddling ...
Mylan has spent more than $460 million buying Novartis cystic fibrosis products. Now, it wants the plant that makes them. Mylan took an option on a Novartis plant in San Carlos, California, when it ...
Comprehensive report includes a look at Mylan's historical impact on patients, employees, the environment, global public health and the community HERTFORDSHIRE, England and PITTSBURGH, May 4, 2020 ...
PITTSBURGH (KDKA/AP) -- Pfizer is buying Mylan in an all-stock deal and combining the $10 billion generic pharmaceutical company with its own off-patent branded and generic business. The Pfizer ...
Mylan Chairman, and incoming Viatris Executive Chairman, Robert J. Coury said: “I am pleased to welcome Mr. Cornwell to the Viatris board. Having spent time getting to know him, I am confident that ...
Heather Bresch, Mylan CEO said, "Mylan was founded nearly 60 years ago with the core purpose to provide access to medicine. Thanks to the hard work and dedication of thousands of Mylan employees and ...
One of the world’s largest generic drugmakers and a division of one of the largest pharmaceutical companies are combining to create a new pharmaceutical company. Pittsburgh-based Mylan and Upjohn – ...
(Reuters) - U.S. regulators said on Wednesday that Mylan NV's EpiPen products are in shortage due to manufacturing delays that are creating intermittent supply constraints of the emergency allergy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results